Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ADBE -3.6%, NUE -2.5% (guidance), MWA -0.8%
Other news:
- OCUL -17% (prices offering of 30.8 mln shares of common stock at $3.25 per share)
- APLS -14.1% (Provides update on ongoing regulatory review of pegcetacoplan for GA in the European Union)
- MDRX -10% (announces that Nasdaq Hearings Panel has granted its continued listing pending return to compliance with Nasdaq filing requirements)
- ASLE -9.4% (prices secondary offering of 4.0 mln shares of common stock by selling shareholders)
- PBA -2.9% (purchasing stakes in two of ENB's pipelines for $3.1 bln)
- ACAD -2.2% (Delaware District Court Rules in Favor of Acadia on Formulation Patent Construction (Markman) Claims Regarding NUPLAZID (pimavanserin); also downgraded to Hold from Buy at Deutsche Bank)
- ARR -1.3% (reduces monthly dividend to $0.24 per share for January down from $0.40 pre share prior)
Analyst comments:
- GDOT -2.8% (downgraded to Underweight from Equal Weight at Barclays)